German prosthetics maker Ottobock saw its shares climb 9% on debut in Frankfurt after raising €808m in Germany’s biggest IPO since March 2024. The stock opened at €72, above the €66 offer price, giving the company a market capitalisation of €4.2bn, according to a report by Reuters.

Founded in 1919, Ottobock is the world’s leading manufacturer of prosthetics and orthotic devices. The IPO marks its return to public markets after shelving an earlier attempt in 2022 amid geopolitical volatility.

The Naeder family, descendants of founder Otto Bock, retains an 81% stake in the company and will receive most of the offering’s proceeds, while Ottobock itself will collect €100m to fund future expansion. The family plans to gradually reduce its holdings to 70–75% after a 180-day lock-up period, according to the prospectus.

A portion of the proceeds will be used to repay private credit loans taken to finance the family’s €1bn buyback of EQT’s minority stake last year. Cornerstone investors include Hamburg billionaire Klaus-Michael Kühne and Capital Group.

Ottobock’s IPO follows a resurgence of listings across Europe, including Verisure’s €13.7bn Stockholm debut and Swiss Marketplace Group’s Zurich flotation, marking a revival in regional deal activity.

CEO Oliver Jakobi said the company continues to invest in innovation, particularly bionic prosthetics and exoskeletons designed to enhance mobility and workplace safety. The firm reported a sharp rise in demand since 2022, with prosthetic sales doubling following the outbreak of the war in Ukraine.

Ottobock’s revenue from Russia, which accounted for about 8% of sales in the first half of 2025, remains legally permissible as medical products are exempt from Western sanctions.

If you think we missed any important news, please do not hesitate to contact us at news@pe-insights.com.

Can`t stop reading? Read more.